Olshan Client CorMedix Announces $12 Million IPO
Firm News
Olshan’s client CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, announced the completion of its $12 million IPO. Yehuda Markovits and Kenneth S. Mantel, with assistance from Kenneth A. Schlesinger and Michael D. DeDonato, represented CorMedix.
Media Contact
Marketing Contact
Mizi Mehaj
Director of Marketing
mmehaj@olshanlaw.com
212.451.2319
Public Relations Contact
Promova, LLC
info@getpromova.com
(407) 603-1444
www.getpromova.com
Mizi Mehaj
Director of Marketing
mmehaj@olshanlaw.com
212.451.2319
Public Relations Contact
Promova, LLC
info@getpromova.com
(407) 603-1444
www.getpromova.com